GENELABS TECHNOLOGIES INC Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Entry into a Material Definitive Agreement (Filed With SEC on November 3, 2008)
- Entry into a Material Definitive Agreement (Filed With SEC on November 3, 2008)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on October 30, 2008)
- our ability to secure sufficient funds as a going concern (Filed With SEC on August 13, 2007)
- our ability to secure sufficient funds as a going concern (Filed With SEC on May 14, 2007)
- our ability to remain listed on the Nasdaq Capital Market (Filed With SEC on August 3, 2006)
- our ability to secure sufficient funds to continue as a going concern (Filed With SEC on March 31, 2006)
- our ability to secure sufficient funds to continue as a going concern (Filed With SEC on March 31, 2006)
- our ability to secure sufficient funds to continue as a going concern (Filed With SEC on March 31, 2006)
- results and analysis of our recent Prestara Phase III clinical trial in the United States and the follow-on open label clinical trial (Filed With SEC on November 4, 2004)
- estimates relating to the timing and completion of our pending clinical trials (Filed With SEC on May 7, 2004)
